Global Follicle Stimulating Hormone Market Report 2024

Follicle Stimulating Hormone Global Market Report 2024 – By Type (Recombinant FSH, Urinary FSH), By Application (Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications), By End-Users (Infertility Center, Hospitals, Other End-Users ) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Follicle Stimulating Hormone Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Follicle Stimulating Hormone Market Definition And Segments

Follicle-stimulating hormone is a hormone that the pituitary gland secretes and is involved in sexual maturation and reproduction. It has an impact on how well the testicles and ovaries work. Follicle-stimulating hormone assists in regulating both the ovaries' egg production and the menstrual cycle.

The main types of follicles stimulating hormones are recombinant FSH and urinary FSH. Recombinant FSH (Follicle-Stimulating Hormone) is a type of FSH that is synthesized using recombinant DNA technology instead of being sourced from natural sources like urine. These are used for several applications, including infertility treatment, assisted reproductive technology (ART), and others, which are used by various end-users, such as infertility centers, hospitals, and others.

The follicle stimulating hormone market covered in this report is segmented –

1) By Type: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

The follicle stimulating hormone market size has grown strongly in recent years. It will grow from $1.94 billion in 2023 to $2.05 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increased prevalence of hormonal disorders, growing demand for fertility treatment, expansion of FSH indications, market entry of new FSH products, growing demand for safe and effective contraceptive options.

The follicle stimulating hormone market size is expected to see steady growth in the next few years. It will grow to $2.49 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to widening therapeutic applications, rising demand for combination therapy, growing need for effective contraceptive options, aging population and related healthcare needs, market expansion in key regions. Major trends in the forecast period include advanced biosimilar FSH products, regulatory approvals and market access, technological advancements in FSH production and delivery, growing need for effective contraceptive options.

The Role Of Follicle-Stimulating Hormone In Addressing The Growing Prevalence Of Infertility

The increasing prevalence of infertility is expected to propel the growth of the follicle-stimulating hormone market. Infertility is a condition affecting the male or female reproductive system that is indicated by the inability to conceive after 12 months or longer of frequent, unprotected sexual contact. Follicle-stimulating hormone encourages the development of eggs in the ovaries and aids in regulating the menstrual cycle in females. It promotes testicular growth in men and aids in producing a protein essential for male fertility by promoting the development of healthy sperm cells. For instance, in April 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, infertility affected around 1 in 6 adults worldwide, or about 17.5% of the adult population. Furthermore, in October 2023, according to the Australian Bureau of Statistics, an Australia-based self-governing constitutional organization entrusted with gathering and analyzing information and making fact-based recommendations to the national, state, and territory governments, there were 300,684 recorded births in 2022, a 3% drop from 2021. The overall fertility rate for all Australian women was 1.63 births per woman. Therefore, the increasing prevalence of infertility is driving the growth of the follicle-stimulating hormone market.

Follicle-Stimulating Hormone Market Surges With The Rising Adoption Of Assisted Reproductive Technology

The increasing adoption of assisted reproductive technology is expected to propel the growth of the follicle-stimulating hormone market in the coming years. Assisted Reproductive Technology (ART) is a term for medical procedures or practices that help people or couples conceive when traditional means have failed. The use of follicle-stimulating hormone in assisted reproductive technology is a well-established therapy that tries to improve the odds of a successful pregnancy for people or couples who are experiencing reproductive issues. For instance, in September 2023, according to the CDC’s 2021 Fertility Clinic Success Rates Report, a report released by the Centers for Disease Control and Prevention, a US-based governmental agency within the Department of Health and Human Services, about 238,126 individuals underwent 413,776 ART cycles at 453 registered clinics in the United States in 2021, leading to 91,906 live births (the delivery of one or more alive children) and 97,128 live-born newborns. Therefore, the increasing adoption of assisted reproductive technology is driving the follicle-stimulating hormone market.

Major companies operating in the follicle stimulating hormone market report are Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Nihon Kohden Corp., Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Electrical Geodesics Inc., Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.

Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility Treatment

Product innovations are a key trend gaining popularity in the follicle-stimulating hormone market. Major companies operating in the follicle-stimulating hormone market are focused on developing innovative products to strengthen their position in the market. For instance, in August 2021, Merck Specialties Pvt. Ltd., an India-based healthcare company, introduced the Pergoveris Pen, aiming to enhance infertility treatment options in the country. The Pergoveris Pen is an innovative device that combines recombinant follicle-stimulating hormone (FSH) and recombinant luteinizing hormone (LH) in a convenient, pre-filled format. It is the first to combine these hormones within a pen injector. Designed for prescribed use by IVF specialists, the Pergoveris Pen offers a combination treatment solution specifically for women experiencing severe deficiencies in follicle stimulating hormone (FSH) and luteinizing hormone (LH).

Innovative Advancements In The Follicle-Stimulating Hormone Market

Major companies operating in the follicle-stimulating hormone market are developing innovative products such as estrogen-based pills to enhance product offerings and gain a competitive advantage. Estrogen-based pills are drugs containing estrogen, a hormone that is essential in the growth and management of the female reproductive system. For instance, in August 2022, Myovant Sciences Ltd., a UK-based biopharmaceutical company, and Pfizer Inc., a US-based pharmaceutical and biotechnology firm, announced that MYFEMBREE (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) had been authorized by the US Food and Drug Administration (FDA) as a one-pill treatment. MYFEMBREE is a once-daily medicine used to treat moderate to severe pain caused by endometriosis in premenopausal women for up to 24 months. The authorization is based on one-year effectiveness and safety data, including 24-week data from the Lancet-published Phase 3 SPIRIT 1 and SPIRIT 2 studies, as well as the first 28 weeks of an open-label extension study for eligible women who finished either SPIRIT 1 or SPIRIT 2. MYFEMBREE is also authorized for premenopausal women for excessive menstrual bleeding caused by uterine fibroids. Myovant and Pfizer intend to keep jointly marketing MYFEMBREE in the United States.

Organon Expands Women's Health Portfolio With Strategic Acquisition Of Follicle-Stimulating Hormone Provider Forendo Pharma

In November 2021, Organon, a US-based healthcare company, acquired Forendo Pharma for an undisclosed amount. With this acquisition, Organon aims to enhance its portfolio of women's health treatments. Forendo Pharma is a Finland-based clinical-stage drug development company offering follicle-stimulating hormones.

North America was the largest region in the follicle stimulating hormone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the follicle stimulating hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The follicle-stimulating hormone market consists of sales of luteinizing hormone (LH), chorionic gonadotropin (CG), and thyroid-stimulating hormone. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The follicle stimulating hormone market research report is one of a series of new reports from The Business Research Company that provides follicle stimulating hormone market statistics, including follicle stimulating hormone industry global market size, regional shares, competitors with a follicle stimulating hormone market share, detailed follicle stimulating hormone market segments, market trends and opportunities, and any further data you may need to thrive in the follicle stimulating hormone industry. This follicle stimulating hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Follicle Stimulating Hormone Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.05 billion
Revenue Forecast In 2033 $2.49 billion
Growth Rate CAGR of 5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Recombinant FSH, Urinary FSH
2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications
3) By End-Users: Infertility Center, Hospitals, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Novartis AG; Abbott Laboratories; Sanofi S.A.; Boehringer Ingelheim GmbH; Merck KGaA; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Intas Pharmaceuticals Ltd.; Cipla Ltd.; Ferring Pharmaceuticals Inc.; Lupin Limited; Zydus Lifesciences Limited; Livzon Pharmaceutical Group Inc.; Emcure Pharmaceuticals Ltd.; LG Chem's life sciences; IBSA Group; Bharat Serums and Vaccines Limited; Nihon Kohden Corp.; Anhui Anke Biotechnology Group Co. Ltd.; Taj Pharmaceuticals Ltd.; Genpharm Inc.; Cadwell Laboratories Inc.; Creative BioMart; Electrical Geodesics Inc.; Lee Biosolutions Inc.; Trumac Healthcare; Midas Pharma GmbH; Biogenix Inc. Pvt. Ltd.; Shanghai Techwell Biopharmaceutical Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Follicle Stimulating Hormone Market Characteristics

    3. Follicle Stimulating Hormone Market Trends And Strategies

    4. Follicle Stimulating Hormone Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Follicle Stimulating Hormone Market Size and Growth

    5.1. Global Follicle Stimulating Hormone Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Follicle Stimulating Hormone Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Follicle Stimulating Hormone Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Follicle Stimulating Hormone Market Segmentation

    6.1. Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Recombinant FSH

    Urinary FSH

    6.2. Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Infertility Treatment

    Assisted Reproductive Technology (ART)

    Other Applications

    6.3. Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Infertility Center

    Hospitals

    Other End-Users

    7. Follicle Stimulating Hormone Market Regional And Country Analysis

    7.1. Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Follicle Stimulating Hormone Market

    8.1. Asia-Pacific Follicle Stimulating Hormone Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Follicle Stimulating Hormone Market

    9.1. China Follicle Stimulating Hormone Market Overview

    9.2. China Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Follicle Stimulating Hormone Market

    10.1. India Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Follicle Stimulating Hormone Market

    11.1. Japan Follicle Stimulating Hormone Market Overview

    11.2. Japan Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Follicle Stimulating Hormone Market

    12.1. Australia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Follicle Stimulating Hormone Market

    13.1. Indonesia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Follicle Stimulating Hormone Market

    14.1. South Korea Follicle Stimulating Hormone Market Overview

    14.2. South Korea Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Follicle Stimulating Hormone Market

    15.1. Western Europe Follicle Stimulating Hormone Market Overview

    15.2. Western Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Follicle Stimulating Hormone Market

    16.1. UK Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Follicle Stimulating Hormone Market

    17.1. Germany Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Follicle Stimulating Hormone Market

    18.5. France Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Follicle Stimulating Hormone Market

    19.9. Italy Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Follicle Stimulating Hormone Market

    20.13. Spain Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Follicle Stimulating Hormone Market

    21.1. Eastern Europe Follicle Stimulating Hormone Market Overview

    21.2. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Follicle Stimulating Hormone Market

    22.1. Russia Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Follicle Stimulating Hormone Market

    23.1. North America Follicle Stimulating Hormone Market Overview

    23.2. North America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Follicle Stimulating Hormone Market

    24.1. USA Follicle Stimulating Hormone Market Overview

    24.2. USA Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Follicle Stimulating Hormone Market

    25.1. Canada Follicle Stimulating Hormone Market Overview

    25.2. Canada Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Follicle Stimulating Hormone Market

    26.1. South America Follicle Stimulating Hormone Market Overview

    26.2. South America Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Follicle Stimulating Hormone Market

    27.1. Brazil Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Follicle Stimulating Hormone Market

    28.1. Middle East Follicle Stimulating Hormone Market Overview

    28.2. Middle East Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Follicle Stimulating Hormone Market

    29.1. Africa Follicle Stimulating Hormone Market Overview

    29.2. Africa Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Follicle Stimulating Hormone Market Competitive Landscape And Company Profiles

    30.1. Follicle Stimulating Hormone Market Competitive Landscape

    30.2. Follicle Stimulating Hormone Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Novartis AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Abbott Laboratories

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Sanofi S.A.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Boehringer Ingelheim GmbH

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Follicle Stimulating Hormone Market Other Major And Innovative Companies

    31.1. Merck KGaA

    31.2. Teva Pharmaceutical Industries Ltd.

    31.3. Sun Pharmaceutical Industries Ltd.

    31.4. Intas Pharmaceuticals Ltd.

    31.5. Cipla Ltd.

    31.6. Ferring Pharmaceuticals Inc.

    31.7. Lupin Limited

    31.8. Zydus Lifesciences Limited

    31.9. Livzon Pharmaceutical Group Inc.

    31.10. Emcure Pharmaceuticals Ltd.

    31.11. LG Chem's life sciences

    31.12. IBSA Group

    31.13. Bharat Serums and Vaccines Limited

    31.14. Nihon Kohden Corp.

    31.15. Anhui Anke Biotechnology Group Co. Ltd.

    32. Global Follicle Stimulating Hormone Market Competitive Benchmarking

    33. Global Follicle Stimulating Hormone Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Follicle Stimulating Hormone Market

    35. Follicle Stimulating Hormone Market Future Outlook and Potential Analysis

    35.1 Follicle Stimulating Hormone Market In 2028 - Countries Offering Most New Opportunities

    35.2 Follicle Stimulating Hormone Market In 2028 - Segments Offering Most New Opportunities

    35.3 Follicle Stimulating Hormone Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Novartis AG Financial Performance
  • Table 76: Abbott Laboratories Financial Performance
  • Table 77: Sanofi S.A. Financial Performance
  • Table 78: Boehringer Ingelheim GmbH Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Follicle Stimulating Hormone Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Follicle Stimulating Hormone Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Follicle Stimulating Hormone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Follicle Stimulating Hormone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Follicle Stimulating Hormone Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Novartis AG Financial Performance
  • Figure 76: Abbott Laboratories Financial Performance
  • Figure 77: Sanofi S.A. Financial Performance
  • Figure 78: Boehringer Ingelheim GmbH Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Hormone Therapy Global Market Report 2024 – By Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By Indication (Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Parathyroid Hormone Global Market Report 2024 – By Disease Type (Hypocalcemia, Hypoparathyroidism), By Product Type (Recombinant Parathtyoid Hormone, Parathyroid Hormone Analogues), By End-User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biosimilar Hormones Global Market Report 2024 – By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types), By Application (Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics, Other Applications), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/pharmacy, Specialty Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biosimilar Growth Hormones Global Market Report 2024 – By Route Of Administration (Intravenous, Subcutaneous, Intramuscular, Oral), By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Assisted Reproductive Technology Global Market Report 2024 – By Diagnosis (Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing), By Procedure Type (Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking), By End-User (Hospitals, Fertility Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Ovarian Cancer Diagnostics Global Market Report 2024 – By Product Type (Instruments, Kits, Reagents), By Diagnosis Type (Biopsy, Blood Test, Imaging, Other Diagnosis Types), By Cancer Type (Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor, Other Cancer Types), By End User (Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Polycystic Ovarian Syndrome Treatment Global Market Report 2024 – By Drug Type (Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors), By Surgery Type (Ovarian Wedge Resection, Laparoscopic Ovarian Drilling), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Gynecology Centers, Feminist Health Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Ovarian Cancer Drugs Global Market Report 2024 – By Tumor Type (Epithelial Ovarian Cancer, Germ Cell Ovarian Cancer, Stromal Cell Ovarian Cancer), By Drug Type (Alkylating Agents, Mitotic Inhibitors, VEGF/VEGFR inhibitors, PARP inhibitors, Other Drug Types), By Distribution Channel (Hospital Pharmacies, Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the follicle stimulating hormone market?

Follicle-stimulating hormone is a hormone that the pituitary gland secretes and is involved in sexual maturation and reproduction. It has an impact on how well the testicles and ovaries work. Follicle-stimulating hormone assists in regulating both the ovaries' egg production and the menstrual cycle. For further insights on the follicle stimulating hormone market, request a sample here

How will the follicle stimulating hormone market drivers and restraints affect the follicle stimulating hormone market dynamics? What forces will shape the follicle stimulating hormone industry going forward?

The follicle stimulating hormone market major growth driver - The Role Of Follicle-Stimulating Hormone In Addressing The Growing Prevalence Of Infertility. For further insights on the follicle stimulating hormone market, request a sample here

What is the forecast market size or the forecast market value of the follicle stimulating hormone market?

The follicle stimulating hormone market size has grown strongly in recent years. It will grow from $1.94 billion in 2023 to $2.05 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increased prevalence of hormonal disorders, growing demand for fertility treatment, expansion of fsh indications, market entry of new fsh products, growing demand for safe and effective contraceptive options. The follicle stimulating hormone market size is expected to see steady growth in the next few years. It will grow to $2.49 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to widening therapeutic applications, rising demand for combination therapy, growing need for effective contraceptive options, aging population and related healthcare needs, market expansion in key regions. Major trends in the forecast period include advanced biosimilar fsh products, regulatory approvals and market access, technological advancements in fsh production and delivery, growing need for effective contraceptive options. For further insights on the follicle stimulating hormone market, request a sample here

How is the follicle stimulating hormone market segmented?

The follicle stimulating hormone market is segmented
1) By Type: Recombinant FSH, Urinary FSH
2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications
3) By End-Users: Infertility Center, Hospitals, Other End-Users For further insights on the follicle stimulating hormone market, request a sample here

Which region has the largest share of the follicle stimulating hormone market? What are the other regions covered in the report?

North America was the largest region in the follicle stimulating hormone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the follicle stimulating hormone market, request a sample here.

Who are the major players in the follicle stimulating hormone market?

Major companies operating in the follicle stimulating hormone market report are Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem's life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Nihon Kohden Corp., Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Electrical Geodesics Inc., Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd. For further insights on the follicle stimulating hormone market, request a sample here.

What are the key trends in the follicle stimulating hormone market?

Major trend in the follicle stimulating hormone market - Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility Treatment. For further insights on the follicle stimulating hormone market, request a sample here.

What are the major opportunities in the follicle stimulating hormone market? What are the strategies for the follicle stimulating hormone market?

For detailed insights on the major opportunities and strategies in the follicle stimulating hormone market, request a sample here.

How does the follicle stimulating hormone market relate to the overall economy and other similar markets?

For detailed insights on follicle stimulating hormone market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the follicle stimulating hormone industry?

For detailed insights on the mergers and acquisitions in the follicle stimulating hormone industry, request a sample here.

What are the key dynamics influencing the follicle stimulating hormone market growth? SWOT analysis of the follicle stimulating hormone market.

For detailed insights on the key dynamics influencing the follicle stimulating hormone market growth and SWOT analysis of the follicle stimulating hormone industry, request a sample here.